CPT code 87481 represents a laboratory test for the detection of Candida species using an amplified nucleic acid probe technique. This code is significant in clinical practice for its role in diagnosing fungal infections, which are increasingly relevant in both outpatient and inpatient settings. The procedure is commonly performed in independent laboratories, ensuring precise identification of Candida, a key pathogen in genitourinary and other systemic infections.

Major national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides a comprehensive overview of payer coverage, clinical context, and policy benchmarks related to CPT code 87481. Readers will gain insights into coding practices, typical sites of service, and the importance of accurate laboratory testing for infectious agents. The summary also highlights relevant modifiers and associated taxonomies, offering a clear understanding of how this code fits into broader laboratory and pathology billing workflows.

This article is designed for healthcare professionals, billing specialists, and policy analysts seeking up-to-date information on laboratory testing for Candida species. It covers essential details for compliance, reimbursement, and clinical application, supporting informed decision-making in medical billing and laboratory operations.